Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice

Show other versions (1)

The International Society for Clinical Densitometry (ISCD) and the International Osteoporosis Foundation (IOF) convened the FRAX® Position Development Conference (PDC) in Bucharest, Romania, on November 14, 2010, following a two-day joint meeting of the ISCD and IOF on the "Interpretation and U...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Hans, D, Kanis, J, Baim, S, Bilezikian, J, Binkley, N, Cauley, J, Compston, J, Cooper, C, Dawson-Hughes, B, El-Hajj Fuleihan, G, Leslie, W, Lewiecki, E, Luckey, M, McCloskey, E, Papapoulos, SE, Poiana, C, Rizzoli, R
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2011

Eitemau Tebyg

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
gan: Hans, D, et al.
Cyhoeddwyd: (2011)

Interpretation and use of FRAX in clinical practice.
gan: Kanis, J, et al.
Cyhoeddwyd: (2011)

Worldwide uptake of FRAX.
gan: Kanis, J, et al.
Cyhoeddwyd: (2014)

The US FRAX filter: avoiding confusion or hindering progress?
gan: McCloskey, E, et al.
Cyhoeddwyd: (2010)

The US FRAX® filter: avoiding confusion or hindering progress?
gan: McCloskey, E, et al.
Cyhoeddwyd: (2010)

FRAXE and mental retardation.
gan: Mulley, J, et al.
Cyhoeddwyd: (1995)

Flawed validation of FRAX
gan: Collins, G, et al.
Cyhoeddwyd: (2016)

Conflicts at the heart of the FRAX tool.
gan: Järvinen, T, et al.
Cyhoeddwyd: (2014)

Fracture prediction in rheumatoid arthritis: validation of FRAX with bone mineral density for incident major osteoporotic fractures
gan: Richards, C, et al.
Cyhoeddwyd: (2023)

Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data.
gan: Hamel, B, et al.
Cyhoeddwyd: (1994)

Fracture risk estimation through the FRAX® scale
gan: Prieto-Alhambra, D, et al.
Cyhoeddwyd: (2010)

Expansion and methylation status at FRAXE can be detected on EcoRI blots used for FRAXA diagnosis: analysis of four FRAXE families with mild mental retardation in males.
gan: Biancalana, V, et al.
Cyhoeddwyd: (1996)

Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population
gan: Azagra Ledesma, R, et al.
Cyhoeddwyd: (2011)

[Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
gan: Azagra Ledesma, R, et al.
Cyhoeddwyd: (2011)

Fracture Risk Assessment Using DXA and FRAX in Patients with Celiac Disease
gan: Canavan, J, et al.
Cyhoeddwyd: (2009)

BENEFIT OF USING FRAX TO TARGET DXA USE IN A SPANISH POPULATION
gan: Alhambra, D, et al.
Cyhoeddwyd: (2010)

A candidate gene for mild mental handicap at the FRAXE fragile site.
gan: Chakrabarti, L, et al.
Cyhoeddwyd: (1996)

Is it important to use the international society for clinical densitometry (ISCD) criteria in DXA scan interpretation?
gan: Azagra, R, et al.
Cyhoeddwyd: (2009)

Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.
gan: Flynn, G, et al.
Cyhoeddwyd: (1993)

Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE.
gan: Abrams, M, et al.
Cyhoeddwyd: (1997)

Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap.
gan: Knight, S, et al.
Cyhoeddwyd: (1994)

Do we need to fine-tune the Spanish version of the FRAX predictive tool?
gan: Prieto-Alhambra, D, et al.
Cyhoeddwyd: (2013)

Do We Need to Fine-Tune the Spanish Version of the FRAX Predictive Tool?
gan: Prieto-Alhambra, D, et al.
Cyhoeddwyd: (2012)

Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.
gan: Knight, S, et al.
Cyhoeddwyd: (1993)

International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
gan: Vasikaran, S, et al.
Cyhoeddwyd: (2011)

Population genetics of the FRAXE and FRAXF GCC repeats, and a novel CGG repeat, in Xq28.
gan: Ritchie, R, et al.
Cyhoeddwyd: (1997)

Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities.
gan: Holden, J, et al.
Cyhoeddwyd: (1996)

A study of FRAXE in mentally retarded individuals referred for fragile X syndrome (FRAXA) testing in the United Kingdom.
gan: Knight, S, et al.
Cyhoeddwyd: (1996)

(PREMIER POSTER - AWARD CANDIDATE) TREATMENT GUIDANCE IN WOMEN WITH WRIST FRACTURE: NICE TA161, NOGG AND FRAX
gan: Weeks, C, et al.
Cyhoeddwyd: (2009)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
gan: Rizzoli, R, et al.
Cyhoeddwyd: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
gan: Rizzoli, R, et al.
Cyhoeddwyd: (2011)

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.
gan: Azagra, R, et al.
Cyhoeddwyd: (2012)

Rescue of Fragile X Syndrome phenotypes in Fmr1 KO mice by the small molecule PAK inhibitor FRAX486
gan: Dolan, Bridget M
Cyhoeddwyd: (2012)

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
gan: Govindarajan, Arvind, et al.
Cyhoeddwyd: (2013)

Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
gan: Delmas, P, et al.
Cyhoeddwyd: (2005)

The Positive Theory of International Trade.
gan: Jones, R, et al.
Cyhoeddwyd: (1984)

Prevalence of osteoporotic bone mineral density at the hip in Britain differs substantially from the US over 50 years of age: implications for clinical densitometry.
gan: Holt, G, et al.
Cyhoeddwyd: (2002)

Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
gan: Ström, O, et al.
Cyhoeddwyd: (2011)

Clinical aspects of MuSK antibody positive seronegative MG.
gan: Sanders, D, et al.
Cyhoeddwyd: (2003)

The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey.
gan: O'Neill, T, et al.
Cyhoeddwyd: (1999)